News Agency
Men's Weekly

TransThera initiates IND-Enabling studies for TT-02332, a novel, highly potent and CNS-penetrating NLRP3 inhibitor

  • Written by PR Newswire

NANJING, China and GAITHURSBURG, Md., Feb. 26, 2024 /PRNewswire/ -- TransThera, a clinical-stage biopharmaceutical company dedicated to innovating differentiated drugs globally, today announced the initiation of IND-enabling studies for TT-02332, a potent, selective and highly CNS-penetrating NLRP3 inflammasome inhibitor. The NLRP3...

Read more: TransThera initiates IND-Enabling studies for TT-02332, a novel, highly potent and CNS-penetrating...

How Recruitment Agencies Sydney Help Businesses Find the Right Talent

Hiring the right employees is one of the most important responsibilities for any organisation. Companies need skilled professionals who can contribute to business growth, maintain productivity, and strengthen workplace culture. However, finding the right candidates can be time-consuming and challenging... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion